vs
DocGo Inc.（DCGO）与Privia Health Group, Inc.（PRVA）财务数据对比。点击上方公司名可切换其他公司
Privia Health Group, Inc.的季度营收约是DocGo Inc.的7.2倍（$541.2M vs $74.9M）。Privia Health Group, Inc.净利率更高（1.7% vs -190.0%，领先191.6%）。Privia Health Group, Inc.同比增速更快（17.4% vs -38.0%）。过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs -37.5%）
DocGo Inc.是总部位于美国的移动医疗及按需医疗服务提供商，业务覆盖上门急诊、检测诊断、远程问诊、企业健康管理等领域，服务对象涵盖个人患者、医疗机构、企业客户及公共部门，主要市场为北美地区。
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
DCGO vs PRVA — 直观对比
营收规模更大
PRVA
是对方的7.2倍
$74.9M
营收增速更快
PRVA
高出55.4%
-38.0%
净利率更高
PRVA
高出191.6%
-190.0%
两年增速更快
PRVA
近两年复合增速
-37.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $74.9M | $541.2M |
| 净利润 | $-142.3M | $9.2M |
| 毛利率 | — | — |
| 营业利润率 | -139.6% | 2.1% |
| 净利率 | -190.0% | 1.7% |
| 营收同比 | -38.0% | 17.4% |
| 净利润同比 | -1761.4% | 108.0% |
| 每股收益（稀释后） | $-1.36 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DCGOPRVA
| Q4 25 | $74.9M | $541.2M | ||
| Q3 25 | $70.8M | $580.4M | ||
| Q2 25 | $80.4M | $521.2M | ||
| Q1 25 | $96.0M | $480.1M | ||
| Q4 24 | $120.8M | $460.9M | ||
| Q3 24 | $138.7M | $437.9M | ||
| Q2 24 | $164.9M | $422.3M | ||
| Q1 24 | $192.1M | $415.2M |
净利润DCGOPRVA
| Q4 25 | $-142.3M | $9.2M | ||
| Q3 25 | $-27.8M | $6.9M | ||
| Q2 25 | $-11.2M | $2.7M | ||
| Q1 25 | $-9.4M | $4.2M | ||
| Q4 24 | $-7.6M | $4.4M | ||
| Q3 24 | $5.5M | $3.5M | ||
| Q2 24 | $6.5M | $3.5M | ||
| Q1 24 | $11.2M | $3.0M |
营业利润率DCGOPRVA
| Q4 25 | -139.6% | 2.1% | ||
| Q3 25 | -59.3% | 2.5% | ||
| Q2 25 | -21.7% | 0.6% | ||
| Q1 25 | -14.6% | 1.1% | ||
| Q4 24 | -6.2% | 1.1% | ||
| Q3 24 | 7.3% | 1.3% | ||
| Q2 24 | 6.2% | 1.2% | ||
| Q1 24 | 8.3% | 0.2% |
净利率DCGOPRVA
| Q4 25 | -190.0% | 1.7% | ||
| Q3 25 | -39.2% | 1.2% | ||
| Q2 25 | -13.9% | 0.5% | ||
| Q1 25 | -9.8% | 0.9% | ||
| Q4 24 | -6.3% | 1.0% | ||
| Q3 24 | 4.0% | 0.8% | ||
| Q2 24 | 4.0% | 0.8% | ||
| Q1 24 | 5.8% | 0.7% |
每股收益（稀释后）DCGOPRVA
| Q4 25 | $-1.36 | $0.08 | ||
| Q3 25 | $-0.28 | $0.05 | ||
| Q2 25 | $-0.11 | $0.02 | ||
| Q1 25 | $-0.09 | $0.03 | ||
| Q4 24 | $-0.03 | $0.03 | ||
| Q3 24 | $0.05 | $0.03 | ||
| Q2 24 | $0.06 | $0.03 | ||
| Q1 24 | $0.10 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.0M | $479.7M |
| 总债务越低越好 | $235.6K | — |
| 股东权益账面价值 | $144.0M | $737.2M |
| 总资产 | $217.1M | $1.4B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资DCGOPRVA
| Q4 25 | $51.0M | $479.7M | ||
| Q3 25 | $73.4M | $441.4M | ||
| Q2 25 | $104.2M | $390.1M | ||
| Q1 25 | $79.0M | $469.3M | ||
| Q4 24 | $89.2M | $491.1M | ||
| Q3 24 | $89.5M | $422.0M | ||
| Q2 24 | $66.1M | $387.4M | ||
| Q1 24 | $41.2M | $351.1M |
总债务DCGOPRVA
| Q4 25 | $235.6K | — | ||
| Q3 25 | $249.9K | — | ||
| Q2 25 | $12.6K | — | ||
| Q1 25 | $15.1K | — | ||
| Q4 24 | $17.7K | — | ||
| Q3 24 | $47.7K | — | ||
| Q2 24 | $52.8K | — | ||
| Q1 24 | $60.1K | — |
股东权益DCGOPRVA
| Q4 25 | $144.0M | $737.2M | ||
| Q3 25 | $270.5M | $709.1M | ||
| Q2 25 | $297.3M | $682.9M | ||
| Q1 25 | $309.3M | $659.4M | ||
| Q4 24 | $320.9M | $635.2M | ||
| Q3 24 | $325.2M | $614.9M | ||
| Q2 24 | $315.2M | $595.4M | ||
| Q1 24 | $311.3M | $576.8M |
总资产DCGOPRVA
| Q4 25 | $217.1M | $1.4B | ||
| Q3 25 | $353.8M | $1.4B | ||
| Q2 25 | $408.3M | $1.3B | ||
| Q1 25 | $430.8M | $1.2B | ||
| Q4 24 | $455.6M | $1.1B | ||
| Q3 24 | $493.9M | $1.1B | ||
| Q2 24 | $488.2M | $1.1B | ||
| Q1 24 | $490.7M | $1.0B |
负债/权益比DCGOPRVA
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.5M | $127.5M |
| 自由现金流经营现金流 - 资本支出 | $-12.0M | — |
| 自由现金流率自由现金流/营收 | -16.0% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | — | 13.93× |
| 过去12个月自由现金流最近4个季度 | $29.9M | — |
8季度趋势，按日历期对齐
经营现金流DCGOPRVA
| Q4 25 | $-10.5M | $127.5M | ||
| Q3 25 | $1.7M | $52.0M | ||
| Q2 25 | $33.6M | $8.0M | ||
| Q1 25 | $9.7M | $-24.1M | ||
| Q4 24 | $12.7M | $74.8M | ||
| Q3 24 | $31.1M | $33.2M | ||
| Q2 24 | $36.9M | $34.5M | ||
| Q1 24 | $-10.6M | $-33.1M |
自由现金流DCGOPRVA
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $782.6K | — | ||
| Q2 25 | $32.9M | — | ||
| Q1 25 | $8.2M | — | ||
| Q4 24 | $12.0M | — | ||
| Q3 24 | $30.2M | — | ||
| Q2 24 | $35.9M | — | ||
| Q1 24 | $-11.6M | — |
自由现金流率DCGOPRVA
| Q4 25 | -16.0% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 40.9% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 21.7% | — | ||
| Q1 24 | -6.0% | — |
资本支出强度DCGOPRVA
| Q4 25 | 2.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.5% | — |
现金转化率DCGOPRVA
| Q4 25 | — | 13.93× | ||
| Q3 25 | — | 7.58× | ||
| Q2 25 | — | 2.97× | ||
| Q1 25 | — | -5.70× | ||
| Q4 24 | — | 17.00× | ||
| Q3 24 | 5.67× | 9.38× | ||
| Q2 24 | 5.65× | 9.94× | ||
| Q1 24 | -0.95× | -11.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DCGO
| Transportation Services Segment | $50.2M | 67% |
| Mobile Health Services Segment | $24.8M | 33% |
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
